TickerFacts.

Sionna Therapeutics, Inc. (SION): Shareholders' Equity

Annual figures by period end, from SEC filings.

$306.83M
As of 2025-12-31
$265.77M
As of 2026-06-30
2024-12-31: -$163.71M2025-12-31: $306.83M$306.83M
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$306.83Mn/m2026-03-02, Balance as of period end
2024-12-31-$163.71Mn/a2026-03-02, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Sionna Therapeutics, Inc. (SION)2025-12-31$306.83Mn/m
Omeros Corp (OMER)2025-12-31-$121.23Mn/m
Prothena Corp Public Ltd Co (PRTA)2025-12-31$280.47M-42.4%
ARS Pharmaceuticals, Inc. (SPRY)2025-12-31$114.26M-55.5%
Liquidia Corp (LQDA)2025-12-31$44.75M-43.6%
ADC Therapeutics SA (ADCT)2025-12-31-$185.83Mn/m
Rocket Pharmaceuticals, Inc. (RCKT)2025-12-31$277.22M-40.2%
Amylyx Pharmaceuticals, Inc. (AMLX)2025-12-31$305.26M+85.3%
ArriVent BioPharma, Inc. (AVBP)2025-12-31$307.22M+19.2%

Compare SION, OMER, PRTA, SPRY side by side · Screen every company in Pharmaceutical Preparations ↗